findmyKOL
Clinical trialNCT00660972CompletedPhase 1Interventional

Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment40HIV Infections
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

15 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Ucsd Antiviral Research Center Crs

    San Diego, California, United States

  • University of Colorado Hospital Crs

    Aurora, Colorado, United States

  • Northwestern University Crs

    Chicago, Illinois, United States

  • Ihv Baltimore Treatment Crs

    Baltimore, Maryland, United States

  • Johns Hopkins University Crs

    Baltimore, Maryland, United States

  • Brigham and Women'S Hospital Therapeutics Clinical Research Site (bwh Tcrs) Crs

    Boston, Massachusetts, United States

  • Washington University Therapeutics (wt) Crs

    St Louis, Missouri, United States

  • Harlem Actg Crs

    New York, New York, United States

  • Trillium Health Actg Crs

    Rochester, New York, United States

  • Univ. of Rochester Actg Crs

    Rochester, New York, United States

  • Metrohealth Crs

    Cleveland, Ohio, United States

  • Ohio State University Crs

    Columbus, Ohio, United States

  • the Miriam Hospital Clinical Research Site (tmh Crs) Crs

    Providence, Rhode Island, United States

  • Vanderbilt Therapeutics (vt) Crs

    Nashville, Tennessee, United States

  • Houston Aids Research Team Crs

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2008
Primary completion
31 Jan 2009
Completion
30 Apr 2010
Last update posted
1 Nov 2021
Registered enrollment
40
Registry id
NCT00660972

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.